174 related articles for article (PubMed ID: 20100679)
21. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
22. The use of toxicogenomic data in risk assessment: a regulatory perspective.
Chan VS; Theilade MD
Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
[TBL] [Abstract][Full Text] [Related]
23. A decade of toxicogenomic research and its contribution to toxicological science.
Chen M; Zhang M; Borlak J; Tong W
Toxicol Sci; 2012 Dec; 130(2):217-28. PubMed ID: 22790972
[TBL] [Abstract][Full Text] [Related]
24. Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies-A Case Study With Toxicogenomics.
Chen X; Roberts R; Tong W; Liu Z
Toxicol Sci; 2022 Mar; 186(2):242-259. PubMed ID: 34971401
[TBL] [Abstract][Full Text] [Related]
25. The evolution of bioinformatics in toxicology: advancing toxicogenomics.
Afshari CA; Hamadeh HK; Bushel PR
Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S225-37. PubMed ID: 21177775
[TBL] [Abstract][Full Text] [Related]
26. Genetic toxicology in the 21st century: reflections and future directions.
Mahadevan B; Snyder RD; Waters MD; Benz RD; Kemper RA; Tice RR; Richard AM
Environ Mol Mutagen; 2011 Jun; 52(5):339-54. PubMed ID: 21538556
[TBL] [Abstract][Full Text] [Related]
27. Drivers of and Obstacles to the Adoption of Toxicogenomics for Chemical Risk Assessment: Insights from Social Science Perspectives.
Pain G; Hickey G; Mondou M; Crump D; Hecker M; Basu N; Maguire S
Environ Health Perspect; 2020 Oct; 128(10):105002. PubMed ID: 33112659
[TBL] [Abstract][Full Text] [Related]
28. An approach for integrating toxicogenomic data in risk assessment: the dibutyl phthalate case study.
Euling SY; Thompson CM; Chiu WA; Benson R
Toxicol Appl Pharmacol; 2013 Sep; 271(3):324-35. PubMed ID: 23537663
[TBL] [Abstract][Full Text] [Related]
29. Toxicogenomic profiling of chemically exposed humans in risk assessment.
McHale CM; Zhang L; Hubbard AE; Smith MT
Mutat Res; 2010 Dec; 705(3):172-83. PubMed ID: 20382258
[TBL] [Abstract][Full Text] [Related]
30. Progress in applying genomics in drug development.
Lord PG
Toxicol Lett; 2004 Apr; 149(1-3):371-5. PubMed ID: 15093283
[TBL] [Abstract][Full Text] [Related]
31. Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects.
Kinaret PAS; Serra A; Federico A; Kohonen P; Nymark P; Liampa I; Ha MK; Choi JS; Jagiello K; Sanabria N; Melagraki G; Cattelani L; Fratello M; Sarimveis H; Afantitis A; Yoon TH; Gulumian M; Grafström R; Puzyn T; Greco D
Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32326418
[TBL] [Abstract][Full Text] [Related]
32. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
[TBL] [Abstract][Full Text] [Related]
33. Manually curated transcriptomics data collection for toxicogenomic assessment of engineered nanomaterials.
Saarimäki LA; Federico A; Lynch I; Papadiamantis AG; Tsoumanis A; Melagraki G; Afantitis A; Serra A; Greco D
Sci Data; 2021 Feb; 8(1):49. PubMed ID: 33558569
[TBL] [Abstract][Full Text] [Related]
34. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.
Vahle JL; Anderson U; Blomme EAG; Hoflack JC; Stiehl DP
Regul Toxicol Pharmacol; 2018 Jul; 96():18-29. PubMed ID: 29679677
[TBL] [Abstract][Full Text] [Related]
35. Strategic applications of toxicogenomics in early drug discovery.
Ryan TP; Stevens JL; Thomas CE
Curr Opin Pharmacol; 2008 Oct; 8(5):654-60. PubMed ID: 18760379
[TBL] [Abstract][Full Text] [Related]
36. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
37. Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress.
Williams-Devane CR; Wolf MA; Richard AM
Toxicol Sci; 2009 Jun; 109(2):358-71. PubMed ID: 19332651
[TBL] [Abstract][Full Text] [Related]
38. Bridging the gap between science and policy: an international survey of scientists and policy makers in China and Canada.
Choi BC; Li L; Lu Y; Zhang LR; Zhu Y; Pak AW; Chen Y; Little J
Implement Sci; 2016 Feb; 11():16. PubMed ID: 26852131
[TBL] [Abstract][Full Text] [Related]
39. Public consortium efforts in toxicogenomics.
Mattes WB
Methods Mol Biol; 2008; 460():221-38. PubMed ID: 18449490
[TBL] [Abstract][Full Text] [Related]
40. TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals.
Li HH; Yauk CL; Chen R; Hyduke DR; Williams A; Frötschl R; Ellinger-Ziegelbauer H; Pettit S; Aubrecht J; Fornace AJ
Front Big Data; 2019; 2():36. PubMed ID: 33693359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
